Author of the publication

Diversification of the VH3‐53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS‐CoV‐2 virus variants

, , , , , , , , , , , and . Eur J Immunol, n/a (n/a): e2451056 (apr in press)
DOI: 10.1002/eji.202451056

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade, , , , , , , , , and 3 other author(s). EBioMedicine, (2019)B cell depletion impairs vaccination-induced CD8(+) T cell responses in a type I interferon-dependent manner, , , , , , , , , and 4 other author(s). Ann Rheum Dis, 80 (12): 1537-1544 (2021)Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy, , , , , , , , , and 4 other author(s). Front Immunol, (August 2021)Rituximab to treat prolidase deficiency due to a novel pathogenic copy number variation in PEPD, , , , , , , and . RMD Open, (2023)Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry, , , , , , , , , and 12 other author(s). Antiviral Res, (March 2020)Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells, , , , , , , , , and 10 other author(s). J Control Release, (June 2021)Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals, , , , , , , , , and 12 other author(s). Infect Dis Ther, 9 (4): 837-849 (Dec 1, 2020)Diversification of the VH3‐53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS‐CoV‐2 virus variants, , , , , , , , , and 2 other author(s). Eur J Immunol, n/a (n/a): e2451056 (04 in press)Reply to: "Lack of Kupffer cell depletion in diethylnitrosamine-induced hepatic Inflammation", , and . J Hepatol, 70 (4): 815-816 (April 2019)Reply to: Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers, , and . J Hepatol, 71 (3): 633-635 (September 2019)